Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carsten Spanka

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Bioorganic & Medicinal Chemistry Letters|December 17, 2013
The discovery of potent, orally bioavailable pyrazolo and triazolopyrimidine CXCR2 receptor antagonistsDavid W Porter, Michelle Bradley, Zarin Brown, et al.
Journal of Medicinal Chemistry|September 23, 2011
Discovery of 3-(2,6-dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea (NVP-BGJ398), a potent and selective inhibitor of the fibroblast growth factor receptor family of receptor tyrosine kinaseVito Guagnano, Pascal Furet, Carsten Spanka, et al.
Journal of Medicinal Chemistry|December 18, 2009
N-sulfonylanthranilic acid derivatives as allosteric inhibitors of dengue viral RNA-dependent RNA polymeraseZheng Yin, Yen-Liang Chen, Ravinder Reddy Kondreddi, et al.
Nature|July 29, 2011
Oxysterols direct immune cell migration via EBI2Sébastien Hannedouche, Juan Zhang, Tangsheng Yi, et al.
Journal of Medicinal Chemistry|February 17, 2025
Discovery of GJG057, a Potent and Highly Selective Inhibitor of Leukotriene C4 SynthaseGebhard Thoma, Wolfgang Miltz, Rudolf Waelchli, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Bioorganic & Medicinal Chemistry Letters|December 17, 2013
The discovery of potent, orally bioavailable pyrazolo and triazolopyrimidine CXCR2 receptor antagonistsDavid W Porter, Michelle Bradley, Zarin Brown, et al.
Journal of Medicinal Chemistry|September 23, 2011
Discovery of 3-(2,6-dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea (NVP-BGJ398), a potent and selective inhibitor of the fibroblast growth factor receptor family of receptor tyrosine kinaseVito Guagnano, Pascal Furet, Carsten Spanka, et al.
Journal of Medicinal Chemistry|December 18, 2009
N-sulfonylanthranilic acid derivatives as allosteric inhibitors of dengue viral RNA-dependent RNA polymeraseZheng Yin, Yen-Liang Chen, Ravinder Reddy Kondreddi, et al.
Nature|July 29, 2011
Oxysterols direct immune cell migration via EBI2Sébastien Hannedouche, Juan Zhang, Tangsheng Yi, et al.
Journal of Medicinal Chemistry|February 17, 2025
Discovery of GJG057, a Potent and Highly Selective Inhibitor of Leukotriene C4 SynthaseGebhard Thoma, Wolfgang Miltz, Rudolf Waelchli, et al.
Pageof 2